Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53

Journal of Virology

Volumn 86, Issue 20, 2012, Pages 11386-11391

  Ansari, Tina ^a   Brimer, Nicole ^a   Pol, Scott B Vande ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; PROTEIN E6; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ARTICLE; EMBRYO; HUMAN PAPILLOMAVIRUS TYPE 16; IN VIVO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE;

ANIMALS; CELL LINE; HUMAN PAPILLOMAVIRUS 16; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS, VIRAL; PEPTIDE FRAGMENTS; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84869072384     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01236-12     Document Type: Article

References (27)

1. Brimer N, Lyons C, Wallberg AE, Vande Pol SB. 16 January 2012. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and Notch signaling. Oncogene. doi:10.1038/ onc.2011.589.
2. Camus S, et al. 2007. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 26:4059-4070.
3. Charbonnier S, Zanier K, Masson M, Trave G. 2006. Capturing proteinprotein complexes at equilibrium: the holdup comparative chromatographic retention assay. Protein Expr. Purif. 50:89-101.
4. Chen JJ, Hong Y, Rustamzadeh E, Baleja JD, Androphy EJ. 1998. Identification of an alpha helical motif sufficient for association with papillomavirus E6. J. Biol. Chem. 273:13537-13544.
5. Cooper B, et al. 2003. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306: 87-99.
6. Elston RC, Napthine S, Doorbar J. 1998. The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP. J. Gen. Virol. 79:371-374.
7. Howie HL, et al. 2011. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog. 7:e1002211. doi: 10.1371/journal.ppat.1002211.
8. Huibregtse JM, Scheffner M, Howley PM. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129-4135.
9. Huibregtse JM, Scheffner M, Howley PM. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775-784.
10. Huibregtse JM, Scheffner M, Howley PM. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13: 4918-4927.
11. Lin J, Chen J, Elenbaas B, Levine AJ. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235-1246.
12. Massimi P, Shai A, Lambert P, Banks L. 2008. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 27:1800-1804.
13. Mohana-Borges R, et al. 2000. LexA repressor forms stable dimers in solution. The role of specific DNA in tightening protein-protein interactions. J. Biol. Chem. 275:4708-4712.
14. Olsson A, Manzl C, Strasser A, Villunger A. 2007. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ. 14:1561-1575.
15. Ristriani T, Fournane S, Orfanoudakis G, Trave G, Masson M. 2009. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPVpositive HeLa cervical cancer cells. Oncogene 28:762-772.
16. Rozenblatt-Rosen O, et al. 2012. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487:491-495.
17. Scheffner M, Huibregtse JM, Howley PM. 1994. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-APdependent ubiquitination of p53. Proc. Natl. Acad. Sci. U. S. A. 91:8797-8801.
18. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505.
19. Scheffner M, Nuber U, Huibregtse JM. 1995. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373: 81-83.
20. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990 The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
21. Sekaric P, Cherry JJ, Androphy EJ. 2008. Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of hTERT. J. Virol. 82:71-76.
22. Shai A, Nguyen ML, Wagstaff J, Jiang YH, Lambert PF. 2007. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Oncogene 26:3321-3328.
23. Sterlinko Grm H, et al. 2004. Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides. J. Mol. Biol. 335:971-985.
24. Tan MJ, et al. 2012. Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 109:E1473-E1480.
25. Tomaic V, Pim D, Banks L. 2009. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 393:7-10.
26. Vande Pol SB, Brown MC, Turner CE. 1998. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16:43-52.
27. Zanier K, Aould M'hamed ould Sidi, et al. 2012. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure 20:604-617.